An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME)
- PMID: 30255642
- DOI: 10.1111/codi.14376
An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME)
Abstract
Introduction: Transanal total mesorectal excision (TaTME) has rapidly emerged as a novel approach for rectal cancer surgery. Safety profiles are still emerging and more comparative data is urgently needed. This study aimed to compare indications and short-term outcomes of TaTME, open, laparoscopic, and robotic TME internationally.
Methods: A pre-planned analysis of the European Society of Coloproctology (ESCP) 2017 audit was performed. Patients undergoing elective total mesorectal excision (TME) for malignancy between 1 January 2017 and 15 March 2017 by any operative approach were included. The primary outcome measure was anastomotic leak.
Results: Of 2579 included patients, 76.2% (1966/2579) underwent TME with restorative anastomosis of which 19.9% (312/1966) had a minimally invasive approach (laparoscopic or robotic) which included a transanal component (TaTME). Overall, 9.0% (175/1951, 15 missing outcome data) of patients suffered an anastomotic leak. On univariate analysis both laparoscopic TaTME (OR 1.61, 1.02-2.48, P = 0.04) and robotic TaTME (OR 3.05, 1.10-7.34, P = 0.02) were associated with a higher risk of anastomotic leak than non-transanal laparoscopic TME. However this association was lost in the mixed-effects model controlling for patient and disease factors (OR 1.23, 0.77-1.97, P = 0.39 and OR 2.11, 0.79-5.62, P = 0.14 respectively), whilst low rectal anastomosis (OR 2.72, 1.55-4.77, P < 0.001) and male gender (OR 2.29, 1.52-3.44, P < 0.001) remained strongly associated. The overall positive circumferential margin resection rate was 4.0%, which varied between operative approaches: laparoscopic 3.2%, transanal 3.8%, open 4.7%, robotic 1%.
Conclusion: This contemporaneous international snapshot shows that uptake of the TaTME approach is widespread and is associated with surgically and pathologically acceptable results.
Keywords: TME; Rectal cancer; TaTME; laparoscopic surgery; robotic surgery; transanal TME.
Colorectal Disease © 2018 The Association of Coloproctology of Great Britain and Ireland.
Similar articles
-
Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.Surg Endosc. 2019 Aug;33(8):2459-2467. doi: 10.1007/s00464-018-6530-4. Epub 2018 Oct 22. Surg Endosc. 2019. PMID: 30350103 Free PMC article.
-
Comparison of early experience of robotic and transanal total mesorectal excision using propensity score matching.Surg Endosc. 2019 Mar;33(3):757-763. doi: 10.1007/s00464-018-6340-8. Epub 2018 Jul 16. Surg Endosc. 2019. PMID: 30014329
-
Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.Tech Coloproctol. 2016 Apr;20(4):227-34. doi: 10.1007/s10151-015-1421-3. Epub 2016 Jan 21. Tech Coloproctol. 2016. PMID: 26794213
-
Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.Tech Coloproctol. 2023 May;27(5):345-360. doi: 10.1007/s10151-022-02739-1. Epub 2022 Dec 12. Tech Coloproctol. 2023. PMID: 36508067 Review.
-
Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision.BMC Cancer. 2016 Jul 4;16:380. doi: 10.1186/s12885-016-2428-5. BMC Cancer. 2016. PMID: 27377924 Free PMC article. Review.
Cited by
-
Editorial: Colorectal surgery and proctology: past, present, and future.Front Surg. 2024 Feb 1;11:1373867. doi: 10.3389/fsurg.2024.1373867. eCollection 2024. Front Surg. 2024. PMID: 38371881 Free PMC article. No abstract available.
-
Simple transanal total mesorectal resection versus laparoscopic transabdominal total mesorectal resection for the treatment of low rectal cancer: a single-center retrospective case-control study.Front Surg. 2023 Jul 27;10:1171382. doi: 10.3389/fsurg.2023.1171382. eCollection 2023. Front Surg. 2023. PMID: 37576920 Free PMC article.
-
A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer.Front Oncol. 2023 Jun 12;13:1167200. doi: 10.3389/fonc.2023.1167200. eCollection 2023. Front Oncol. 2023. PMID: 37377919 Free PMC article.
-
Outcomes of Robot-Assisted Surgery in Rectal Cancer Compared with Open and Laparoscopic Surgery.Cancers (Basel). 2023 Jan 29;15(3):839. doi: 10.3390/cancers15030839. Cancers (Basel). 2023. PMID: 36765797 Free PMC article. Review.
-
Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.World J Surg Oncol. 2022 Nov 15;20(1):363. doi: 10.1186/s12957-022-02826-5. World J Surg Oncol. 2022. PMID: 36376924 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
